Considering the summation of the apoE immunoreactivity for 34- and 36-kDa (not including the value for the 100-kDa band) species, in samples from AD patients, a significant overall increase in total CSF apoE was found in the Gothenburg cohort and a non-significant trend to increase was seen in the Barcelona cohort compared to controls. Here, APOE is linked to Alzheimer disease.